Phylos Bioscience

Phylos Bioscience

Cannabis genetics company that empowers growers of all sizes to produce high quality cannabis in a cost-effective way.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor

€0.0

round
N/A

€0.0

round
investor

€0.0

round
N/A

€0.0

round
investor investor investor

€0.0

round
N/A

€0.0

Valuation: €0.0

round
investor

€0.0

round
investor

€0.0

round
*

$1.0m

Convertible
Total Funding000k
Notes (0)
More about Phylos Bioscience
Made with AI
Edit

Phylos Bioscience operates at the intersection of agricultural science and data technology, focusing specifically on the cannabis and hemp industries. Founded in 2014 by Nishan Karassik and Mowgli Holmes, the company initially aimed to create a comprehensive genetic map of the cannabis plant, similar to a 23andMe for cannabis. Nishan Karassik's background in technology and sustainable agriculture, combined with Mowgli Holmes's expertise as a molecular biologist, provided the foundational knowledge for this endeavor. Holmes, who holds a PhD from Columbia University, was driven by the potential to apply modern genomic science to a plant with a long, yet poorly documented, history of cultivation.

The company's core business revolves around providing genomic testing and data services to cultivators, breeders, and researchers within the cannabis market. Its primary offering is a suite of genetic tests that can identify a plant's lineage, cannabinoid and terpene profiles, and sex. This information empowers growers to make more informed decisions, optimize their cultivation practices for desired traits, and protect their intellectual property. The business model is primarily service-based, generating revenue from the sale of these testing kits and the associated data analysis. Phylos serves a diverse clientele, ranging from large-scale commercial growers to smaller craft producers and research institutions.

A significant development in the company's trajectory was the introduction of its own proprietary cannabis seeds. This move represented a strategic pivot from being purely a data and testing provider to also becoming a direct supplier of plant genetics. This vertical integration allows Phylos to leverage its vast genetic database to breed new varieties with specific, commercially desirable characteristics, such as high yields or specific chemical profiles. This expansion into seed production provides a new and substantial revenue stream, positioning the company as a key player in the supply chain for cannabis cultivation. The company's database, known as The Phylos Galaxy, has been a central part of its identity, mapping the genetic relationships between thousands of cannabis strains and making this information accessible to its clients.

Keywords: cannabis genetics, hemp genomics, agricultural biotechnology, plant breeding, genetic testing, seed production, cultivation data, molecular biology, crop science, agritech

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo